| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
5,099.20
|
|
Change (%)
|
-0.05 (0.00%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
5,030.60
-
5,160.00
|
|
52-Week Range (RS)
|
3,742.90
-
5,987.65
|
|
Beta (1 Year)
|
0.33
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Pfizer standalone net profit rises 19.37% in the September 2025 quarter |
| Pfizer gains after Q2 PAT rises 19% YoY |
| Pfizer schedules board meeting |
| Pfizer Ltd - Pfizer Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018 : |
| Pfizer Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| Volumes spurt at Star Health & Allied Insurance Company Ltd counter |
| Volumes jump at Pfizer Ltd counter |
| Pfizer Ltd - Pfizer Limited - Trading Window |
| Pfizer standalone net profit rises 27.23% in the June 2025 quarter |
| Pfizer jumps after robust Q1 earnings |
|
|
|
| Incoporation Year : 1950 |
| Chairman : Pradip P Shah |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Pfizer Ltd
The Capital 1802/1901 Plot-C70,
G Bl Bandra Kurla Cpx Bandra-E,
Mumbai,
Maharashtra-400051 |
Phone:91-22-66932000
Fax:91-22-26540274 |
| E-Mail : contactus.india@pfizer.com |
| URL : http://www.pfizerindia.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
12-Dec-2025 |
5003.05 |
1.92 |
| 1Month |
19-Nov-2025 |
5001.50 |
1.95 |
| 3Month |
19-Sep-2025 |
5110.05 |
-0.21 |
| 6Month |
19-Jun-2025 |
5661.40 |
-9.93 |
| 1Year |
19-Dec-2024 |
5012.10 |
1.74 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.88 |
600.04 |
| Quant Small Cap Fund |
1.51 |
454.98 |
| Nippon India Multi Cap Fund |
0.36 |
180.52 |
| ICICI Pru Value Fund |
0.27 |
163.65 |
| Nippon India Pharma Fund |
1.87 |
158.33 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
28,039.30 |
0.59 |
35,921.55 |
25,260.20 |
59,583.51 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,534.60 |
-0.70 |
3,515.95 |
1,924.30 |
42,937.65 |
| Astrazeneca Pharma India Ltd |
9,062.25 |
-0.14 |
10,653.05 |
6,301.00 |
22,655.63 |
| Sanofi Consumer Healthcare India Ltd |
4,590.15 |
-0.40 |
5,954.00 |
4,360.30 |
10,571.40 |
| Procter & Gamble Health Ltd |
5,648.60 |
-0.23 |
6,700.00 |
4,916.00 |
9,376.33 |
|
|
|
|